Abstract

Insights

MicroRNA-155 (miR-155) is significantly upregulated in peripheral blood mononuclear cells (PBMC) of hemodialysis patients compared to healthy individuals. This upregulation is also observed after PHA stimulation, but not significantly altered by hemodialysis sessions.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Context:

  • MicroRNAs (miRNAs) are crucial post-transcriptional regulators of gene expression involved in various pathophysiological processes.
  • Chronic kidney disease patients undergoing hemodialysis exhibit altered cellular functions and inflammatory states.

Purpose:

  • To investigate the expression levels of miR-155 in peripheral blood mononuclear cells (PBMC) from chronic hemodialysis (HD) patients.
  • To compare miR-155 expression in HD patients' PBMC before and after hemodialysis sessions.
  • To assess the effect of phytohemagglutinin (PHA) stimulation on miR-155 expression in HD patients' PBMC.

Summary:

  • Real-Time PCR analysis revealed significantly higher miR-155 relative quantity (RQ) in pre-dialysis PBMC of HD patients compared to healthy controls (3.77-fold increase, P=0.003).
  • PHA stimulation further increased miR-155 RQ in HD patients' PBMC (1.79-fold increase, P=0.019) compared to non-stimulated PBMC.
  • No significant difference in miR-155 expression was observed in HD patients' PBMC before and after hemodialysis sessions.

Impact:

  • These findings indicate a significant upregulation of miR-155 in HD patients' PBMC, suggesting its potential role in the pathophysiology of chronic kidney disease.
  • The observed miR-155 upregulation, particularly after PHA stimulation, may point towards an altered immune response in HD patients.
  • Further research is warranted to elucidate the functional consequences of miR-155 dysregulation in hemodialysis patients.